25 research outputs found
Controlled interfacial assembly of 2D curved colloidal crystals and jammed shells
Assembly of colloidal particles on fluid interfaces is a promising technique
for synthesizing two-dimensional micro-crystalline materials useful in fields
as diverse as biomedicine1, materials science2, mineral flotation3 and food
processing4. Current approaches rely on bulk emulsification methods, require
further chemical and thermal treatments, and are restrictive with respect to
the materials employed5-9. The development of methods that exploit the great
potential of interfacial assembly for producing tailored materials have been
hampered by the lack of understanding of the assembly process. Here we report a
microfluidic method that allows direct visualization and understanding of the
dynamics of colloidal crystal growth on curved interfaces. The crystals are
periodically ejected to form stable jammed shells, which we refer to as
colloidal armour. We propose that the energetic barriers to interfacial crystal
growth and organization can be overcome by targeted delivery of colloidal
particles through hydrodynamic flows. Our method allows an unprecedented degree
of control over armour composition, size and stability.Comment: 18 pages, 5 figure
Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and harmaline are serotonin (5-HT) analogs often abused together, which alters thermoregulation that may indicate the severity of serotonin toxicity. Our recent studies have revealed that co-administration of monoamine oxidase inhibitor harmaline leads to greater and prolonged exposure to 5-HT agonist 5-MeO-DMT that might be influenced by cytochrome P450 2D6 (CYP2D6) status. This study was to define the effects of harmaline and 5-MeO-DMT on thermoregulation in wild-type and CYP2D6-humanized (Tg-CYP2D6) mice, as well as the involvement of 5-HT receptors. Animal core body temperatures were monitored noninvasively in the home cages after implantation of telemetry transmitters and administration of drugs. Harmaline (5 and 15 mg/kg, i.p.) alone was shown to induce hypothermia that was significantly affected by CYP2D6 status. In contrast, higher doses of 5-MeO-DMT (10 and 20 mg/kg) alone caused hyperthermia. Co-administration of harmaline (2, 5 or 15 mg/kg) remarkably potentiated the hyperthermia elicited by 5-MeO-DMT (2 or 10 mg/kg), which might be influenced by CYP2D6 status at certain dose combination. Interestingly, harmaline-induced hypothermia was only attenuated by 5-HT(1A) receptor antagonist WAY-100635, whereas 5-MeO-DMT- and harmaline-5-MeO-DMT-induced hyperthermia could be suppressed by either WAY-100635 or 5-HT(2A) receptor antagonists (MDL-100907 and ketanserin). Moreover, stress-induced hyperthermia under home cage conditions was not affected by WAY-100635 but surprisingly attenuated by MDL-100907 and ketanserin. Our results indicate that co-administration of monoamine oxidase inhibitor largely potentiates 5-MeO-DMT-induced hyperthermia that involves the activation of both 5-HT(1A) and 5-HT(2A) receptors. These findings shall provide insights into development of anxiolytic drugs and new strategies to relieve the lethal hyperthermia in serotonin toxicity